Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BOUNDLESS BIO, INC. (BOLD) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BOUNDLESS BIO, INC. (BOLD), most recent 12 months reported: net loss $64.01M, free cash flow -$56.73M. Latest balance sheet on file: liquid cash $72.63M. From SEC filings. Others in Pharmaceutical Preparations: BIOXYTRAN, INC. · Belite Bio, Inc · Biomea Fusion, Inc. · BENITEC BIOPHARMA INC. · BeyondSpring Inc. · CalciMedica, Inc. · CAPRICOR THERAPEUTICS, INC. · PERSPECTIVE THERAPEUTICS, INC.

Stock screener

Watchlist